Inhibition of heme oxygenase activity in newborn mice by azalanstat

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 10, 2008, Pages 651-659

  Morisawa, Takeshi ^a,b   Wong, Ronald J ^a   Bhutani, Vinod K ^a   Vreman, Hendrik J ^a   Stevenson, David K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Azalanstat; Bilirubin; Carbon monoxide; Heme oxygenase; Imidazole dioxolane; Metalloporphyrins; Neonatal jaundice

Indexed keywords

AZALANSTAT; BILIRUBIN; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; IMIDAZOLE DERIVATIVE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN METABOLISM; BIOLUMINESCENCE; BRAIN; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; LIVER; MOUSE; NEWBORN; NEWBORN JAUNDICE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLEEN; TRANSGENIC MOUSE;

ANILINE COMPOUNDS; ANIMALS; ANIMALS, NEWBORN; BILIRUBIN; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); LUMINESCENCE; METHEMALBUMIN; MICE; MICE, TRANSGENIC; NADP; RNA, MESSENGER; SULFIDES; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC;

EID: 54249167006     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-069     Document Type: Article

References (45)

1. American Academy of Pediatrics. 2004. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 114: 297-316. doi:10.1542/peds.114.1.297. PMID:15231951.
2. Burton, P.M., Swinney, D.C., Heller, R., Dunlap, B., Chiou, M., Malonzo, E., et al. 1995. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity. Biochem. Pharmacol. 50: 529-544. doi:10.1016/0006-2952(95)00152-P. PMID:7646560.
3. Cowan, B.E., Kwong, L.K., Vreman, H.J., and Stevenson, D.K. 1983. The effect of tin protoporphyrin on the bilirubin production rate in newborn rats. Pediatr. Pharmacol. (New York), 3: 95-100. PMID:6689532.
4. DeNagel, D.C., Verity, A.N., Madden, F.E., Yang, C.O., Sangameswaran, L., and Johnson, R.M. 1998. Identification of non-porphyrin inhibitors of heme oxygenase-1. Neuroscience, 24: 2058.
5. Dennery, P.A., Seidman, D.S., and Stevenson, D.K. 2001. Neonatal hyperbilirubinemia. N. Engl. J. Med. 344: 581-590. doi:10.1056/ NEJM200102223440807. PMID:11207355.
6. Dercho, R.A., Nakatsu, K., Wong, R.J., Stevenson, D.K., and Vreman, H.J. 2006. Determination of in vivo carbon monoxide production in laboratory animals via exhaled air. J. Pharmacol. Toxicol. Methods, 54: 288-295. doi:10.1016/j.vascn.2006.01.004. PMID:16540352.
7. DeSandre, G.H., Wong, R.J., Morioka, I., Contag, C.H., and Stevenson, D.K. 2006. The effectiveness of oral tin mesoporphyrin prophylaxis in reducing bilirubin production after an oral heme load in a transgenic mouse model. Biol. Neonate, 89: 139-146. doi:10.1159/000088717. PMID:16205054.
8. Fort, F.L., and Gold, J. 1989. Phototoxicity of tin protoporphyrin, tin mesoporphyrin, and tin diiododeuteroporphyrin under neonatal phototherapy conditions. Pediatrics, 84: 1031-1037. PMID:2531365.
9. Hintz, S.R., Vreman, H.J., and Stevenson, D.K. 1990. Mortality of metalloporphyrin-treated neonatal rats after light exposure. Dev. Pharmacol. Ther. 14: 187-192. PMID:2364856.
10. Jensen, L.E., and Whitehead, A.S. 2004. The 3′ untranslated region of the membrane-bound IL-1R accessory protein mRNA confers tissue-specific destabilization. J. Immunol. 173: 6248-6258. PMID:15528363.
11. Johnson, L., and Brown, A.K. 1999. A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics, 104(Suppl): 736.
12. Kappas, A., Drummond, G.S., Simionatto, C.S., and Anderson, K.E. 1984. Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin. Hepatology, 4: 336-341. PMID:6546735.
13. Kappas, A., Drummond, G.S., Henschke, C., and Valaes, T. 1995. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics, 95: 468-474. PMID:7700742.
14. Kappas, A., Drummond, G.S., Munson, D.P., and Marshall, J.R. 2001a. Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Pediatrics, 108: 1374-1377. doi:10.1542/peds.108.6.1374. PMID:11731664.
15. Kappas, A., Drummond, G.S., and Valaes, T. 2001b. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics, 108: 25-30. doi:10.1542/peds.108.1.25. PMID:11433050.
16. Kinobe, R.T., Vlahakis, J.Z., Vreman, H.J., Stevenson, D.K., Brien, J.F., Szarek, W.A., and Nakatsu, K. 2006. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms. Br. J. Pharmacol. 147: 307-315. doi:10.1038/sj.bjp.0706555. PMID:16331285.
17. Kinobe, R.T., Ji, Y., Vlahakis, J.Z., Motterlini, R., Brien, J.F., Szarek, W.A., and Nakatsu, K. 2007. Effectiveness of novel imidazole-dioxolane heme oxygenase inhibitors in renal proximal tubule epithelial cells. J. Pharmacol. Exp. Ther. 323: 763-770. doi:10.1124/jpet.107.119800. PMID:17761847.
18. Maines, M.D. 1981. Zinc.protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim. Biophys. Acta, 673: 339-350. PMID:6894392.
19. Martinez, J.C., Garcia, H.O., Otheguy, L.E., Drummond, G.S., and Kappas, A. 1999. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics, 103: 1-5. doi:10.1542/peds.103.1.1. PMID:9917431.
20. McCoubrey, W.K., Jr., Huang, T.J., and Maines, M.D. 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247: 725-732. doi:10.1111/j.1432-1033.1997. 00725.x. PMID:9266719.
21. Morioka, I., Wong, R.J., Abate, A., Vreman, H.J., Contag, C.H., and Stevenson, D.K. 2006a. Systemic effects of orally-administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice. Pediatr. Res. 59: 667-672. doi:10.1203/01.pdr.0000215088.71481.a6. PMID:16627879.
22. Morioka, I., Wong, R.J., Vreman, H.J., and Stevenson, D.K. 2006b. Dose-dependent effects of tin mesoporphyrin on heme oxygenase activity inhibition in newborn mice. J. Investig. Med. 54: S128.
23. Pierce, N.W., Wong, R.J., Morioka, I., Vreman, H.J., and Stevenson, D.K. 2006. Metalloporphyrin inhibition of in vitro mouse heme oxygenase isozyme activity. J. Investig. Med. 54: S120-S121.
24. Russell, E.S., and Bernstein, S.E. 1966. Blood and blood formation. In Biology of the laboratory mouse. 2nd ed. Edited by E.L. Green. Dover Publications, New York. Table 17.7.
25. Salomon, W.L., Vreman, H.J., Kwong, L.K., and Stevenson, D.K. 1986. Red cell destruction and bilirubin production in adult rats with short-term biliary obstruction. J. Pediatr. Gastroenterol. Nutr. 5: 806-810. PMID:3761112.
26. Schachter, M. 2005. Chemical, pharmacokinetic and pharmacodynamic properties of statins: An update. Fundam. Clin. Pharmacol. 19: 117-125. doi:10.1111/j.1472-8206.2004.00299.x. PMID:15660968.
27. Seidman, D.S., Paz, I., Stevenson, D.K., Laor, A., Danon, Y.L., and Gale, R. 1991. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics, 88: 828-833. PMID:1896294.
28. Stevenson, D.K., Bartoletti, A.L., Ostrander, C.R., and Johnson, J.D. 1979. Pulmonary excretion of carbon monoxide in the human infant as an index of bilirubin production. II. Infants of diabetic mothers. J. Pediatr. 94: 956-958. doi:10.1016/S0022-3476(79)80232-2. PMID:448545.
29. Stevenson, D.K., Watson, E.M., Hintz, S.R., Kim, C.B., and Vreman, H.J. 1987. Tin protoporphyrin inhibits carbon monoxide production in suckling mice. Biol. Neonate, 51: 40-44. PMID:3828416.
30. Stevenson, D.K., Rodgers, P.A., and Vreman, H.J. 1989. The use of metalloporphyrins for the chemoprevention of neonatal jaundice. Am. J. Dis. Child. 143: 353-356. PMID:2644817.
31. Stevenson, D.K., Vreman, H.J., Wong, R.J., and Contag, C.H. 2001. Carbon monoxide and bilirubin production in neonates. Semin. Perinatol. 25: 85-93. doi:10.1053/sper.2001.23197. PMID:11339670.
32. Sugishima, M., Higashimoto, Y., Oishi, T., Takahashi, H., Sakamoto, H., Noguchi, M., and Fukuyama, K. 2007. X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase. Biochemistry, 46: 1860-1867. doi:10.1021/bi062264p. PMID:17253780.
33. Swinney, D.C., So, O.Y., Watson, D.M., Berry, P.W., Webb, A.S., Kertesz, D.J., et al. 1994. Selective inhibition of mammalian lanosterol 14 alpha-demethylase by RS-21607 in vitro and in vivo. Biochemistry, 33: 4702-4713. doi:10.1021/bi00181a030. PMID:8161528.
34. Tenhunen, R., Marver, H.S., and Schmid, R. 1969. The enzymatic conversion of hemoglobin to bilirubin. Trans. Assoc. Am. Physicians, 82: 363-371. PMID:5375159.
35. Valaes, T., Petmezaki, S., Henschke, C., Drummond, G.S., and Kappas, A. 1994. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics, 93: 1-11. PMID:8265301.
36. Vreman, H.J., and Stevenson, D.K. 1988. Heme oxygenase activity as measured by carbon monoxide production. Anal. Biochem. 168: 31-38. doi:10.1016/0003-2697(88)90006-1. PMID:3364715.
37. Vreman, H.J., and Stevenson, D.K. 1999. Detection of heme oxygenase activity by measurement of CO. In Current protocols in toxicology. Edited by M.D. Maines, L.G. Costa, D.J. Reed, S. Sassa, and I.G. Sipes. John Wiley & Sons, New York. pp. 9.2.1-9.2.10.
38. Vreman, H.J., Rodgers, P.A., Gale, R., and Stevenson, D.K. 1989. Carbon monoxide excretion as an index of bilirubin production in rhesus monkeys. J. Med. Primatol. 18: 449-460. PMID:2614809.
39. Vreman, H.J., Ekstrand, B.C., and Stevenson, D.K. 1993. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr. Res. 33: 195-200. PMID:8433895.
40. Vreman, H.J., Wong, R.J., Stevenson, D.K., and Clark, J.D. 2002. Azalanstat (RS-1607): Evidence for a novel class of potential heme oxygenase inhibitors. Pediatr. Res. 51: 341A.
41. Vreman, H.J., Wong, R.J., Kadotani, T., and Stevenson, D.K. 2005. Determination of carbon monoxide (CO) in rodent tissue: Effect of heme administration and environmental CO exposure. Anal. Biochem. 341: 280-289. doi:10.1016/j.ab.2005.03.019. PMID:15907874.
42. Walker, K.A., Kertesz, D.J., Rotstein, D.M., Swinney, D.C., Berry, P.W., So, O.Y., et al. 1993. Selective inhibition of mammalian lanosterol 14 alpha-demethylase: A possible strategy for cholesterol lowering. J. Med. Chem. 36: 2235-2237. doi:10.1021/jm00067a022. PMID:8340925.
43. Zhang, W., Feng, J.Q., Harris, S.E., Contag, P.R., Stevenson, D.K., and Contag, C.H. 2001. Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression. Transgenic Res. 10: 423-434. doi:10.1023/A:1012042506002. PMID:11708652.
44. Zhang, W., Contag, P.R., Hardy, J., Zhao, H., Vreman, H.J., Hajdena-Dawson, M., et al. 2002. Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1. J. Mol. Med. 80: 655-664. doi:10.1007/s00109-002-0375-x. PMID:12395150.
45. Zhao, H., Wong, R.J., Nguyen, X., Kalish, F., Mizobuchi, M., Vreman, H.J., et al. 2006. Expression and regulation of heme oxygenase isozymes in the developing mouse cortex. Pediatr. Res. 60: 518-523. doi:10.1203/01.PDR. 0000242374.21415.f5. PMID:16966352.